Pharmaceutical Contract Packaging

Global Pharmaceutical Contract Packaging Market to Reach US$57.2 Billion by 2030

The global market for Pharmaceutical Contract Packaging estimated at US$40.8 Billion in the year 2024, is expected to reach US$57.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Primary Packaging, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.7 Billion by the end of the analysis period. Growth in the Secondary Packaging segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.1 Billion While China is Forecast to Grow at 5.4% CAGR

The Pharmaceutical Contract Packaging market in the U.S. is estimated at US$11.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pharmaceutical Contract Packaging Market - Key Trends and Drivers Summarized

What Is Pharmaceutical Contract Packaging and Why Is It Important?

Pharmaceutical contract packaging involves outsourcing the packaging of pharmaceutical products to specialized third-party service providers. This process encompasses a wide range of services, including the design, production, and assembly of packaging materials, as well as labeling, serialization, and quality assurance. The importance of pharmaceutical contract packaging lies in its ability to offer manufacturers flexibility, cost efficiency, and access to advanced technologies. By leveraging the expertise and resources of contract packagers, pharmaceutical companies can focus on their core activities of drug development and marketing. Additionally, contract packaging ensures compliance with stringent regulatory requirements, as these service providers are well-versed in the latest industry standards and guidelines. This guarantees that the packaged products meet the necessary safety and efficacy criteria, ultimately safeguarding patient health.

How Are Technological Advancements Shaping Pharmaceutical Contract Packaging?

Technological advancements are significantly enhancing the capabilities and efficiency of pharmaceutical contract packaging. One of the most notable innovations is the implementation of advanced serialization and traceability solutions, which are crucial for preventing counterfeit drugs and ensuring supply chain integrity. Automation and robotics are also transforming the packaging process, enabling higher precision, consistency, and speed, thereby reducing human error and increasing productivity. The use of smart packaging technologies, such as QR codes and RFID tags, allows for better tracking and monitoring of pharmaceutical products throughout the distribution network. Furthermore, advancements in packaging materials, including the development of more sustainable and eco-friendly options, are addressing environmental concerns and meeting the growing demand for green packaging solutions. These technological strides are making pharmaceutical contract packaging more reliable, secure, and adaptable to the evolving needs of the industry.

What Are the Key Challenges in Pharmaceutical Contract Packaging?

Despite its many benefits, pharmaceutical contract packaging faces several challenges that must be addressed to ensure optimal performance. One of the primary challenges is maintaining compliance with diverse and ever-changing regulatory requirements across different regions. This necessitates continuous monitoring and adaptation to new regulations, which can be resource-intensive. Another significant challenge is ensuring the security and integrity of the supply chain, particularly in the face of rising counterfeit activities and the need for robust serialization and traceability systems. Additionally, the complexity of managing multiple packaging formats and materials, while maintaining high standards of quality and safety, requires sophisticated logistics and quality control mechanisms. Contract packagers must also navigate the pressures of cost containment while investing in advanced technologies and maintaining operational efficiency. Balancing these competing demands is critical for the success and sustainability of pharmaceutical contract packaging services.

 

What Factors Are Driving Growth in the Pharmaceutical Contract Packaging Market?

The growth in the pharmaceutical contract packaging market is driven by several factors. Firstly, the increasing demand for pharmaceutical products globally, spurred by the rising prevalence of chronic diseases and an aging population, is boosting the need for efficient and scalable packaging solutions. Technological advancements, such as automation, smart packaging, and advanced traceability systems, are enhancing the efficiency and security of the packaging process, attracting more pharmaceutical companies to outsource these services. Additionally, the growing focus on sustainability and the development of eco-friendly packaging materials are addressing environmental concerns and aligning with consumer preferences. Regulatory pressures and the need for compliance with stringent standards are also driving pharmaceutical companies to partner with specialized contract packagers who can ensure adherence to industry guidelines. Furthermore, the expansion of the global pharmaceutical supply chain, coupled with the increasing complexity of packaging requirements, is necessitating the expertise and capabilities of contract packaging providers. These factors collectively contribute to the robust growth and evolution of the pharmaceutical contract packaging market.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Contract Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Primary Packaging, Secondary Packaging, Tertiary Packaging); Material (Glass, Plastics & Polymers, Aluminum Foil, Paper & Paperboard, Other Materials)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 57 Featured) -

• AbbVie Contract Manufacturing
• Baxter Biopharma Solutions
• Berlin Packaging LLC
• Catalent Pharma Solutions, Inc.
• CCL Industries, Inc.
• Co-Pak Packaging Corp.
• Daito Pharmaceutical Co., Ltd.
• FedEx Corporation
• FedEx Supply Chain
• Gardan Manufacturing Services
• GPA Global
• Jones Packaging, Inc.
• Multi-Pack Solutions LLC
• Nipro Corporation
• Patheon, Inc.
• PCI Pharma Services
• Pharma Tech Industries (PTI)
• Reelvision Print Limited
• Ropack Pharma Solutions
• Sharp Packaging Services
• Signode Packaging Systems
• TricorBraun, Inc.
• Unicep Packaging, LLC.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.